## FDX: FedEx Corporation - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 1.27 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($269.67)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Jim Cramer Says "FedEx Could Be the Star of the Week"**
- Source: Finviz | 20251216T050806 | Bullish | Relevance: 100%
- Jim Cramer highlighted FedEx Corporation (NYSE: FDX) as a potential "star of the week," praising its operational efficiency and growth in e-commerce. He expects the company to release strong quarterly numbers. Ariel Investments also expressed optimism about FedEx, citing its cost efficiencies, the planned spin-off of FedEx Freight, and potential catalysts like the anniversary of the USPS contract termination.

**2. Jim Cramer Says “FedEx Could Be the Star of the Week”**
- Source: Insider Monkey | 20251215T235100 | Bullish | Relevance: 100%
- Jim Cramer is bullish on FedEx Corporation (NYSE: FDX), predicting it could be the "star of the week" due to its lean operations, furious e-commerce growth, and potential for monster numbers. Ariel Investments also expressed optimism for FDX, citing improved margins, the planned spin-off of FedEx Freight, and operational efficiencies as key catalysts for unlocking significant value. The article suggests that while FDX holds promise, some AI stocks may offer higher returns in a shorter timeframe.

**3. Newly Overvalued Stocks this Week**
- Source: Morningstar | 20251215T160833 | Somewhat-Bearish | Relevance: 100%
- This article identifies 14 US-listed stocks that have recently become overvalued, warranting 1- or 2-star Morningstar Ratings. Key companies like Chubb, FedEx, Seagate Technology, Teva Pharmaceutical Industries, and Fox are highlighted, with details on their fair value estimates, uncertainty ratings, and recent stock performance. The article also explains Morningstar's rating methodology and provides broader market valuation statistics.

**4. FedEx taps Accenture for AI training across 500,000-employee workforce**
- Source: HR Executive | 20251215T130814 | Bullish | Relevance: 100%
- FedEx is collaborating with Accenture to implement an enterprise-wide AI education and literacy program for its 500,000 global employees. This initiative, part of FedEx's transformation into an "AI-powered enterprise," will utilize Accenture's LearnVantage platform to provide personalized, role-based training. The program aims to build common AI fluency and skills across the workforce, enabling employees to apply AI responsibly and effectively within their functions.

**5. Jim Cramer Expects a "Breakout Quarter" From FedEx**
- Source: Finviz | 20251213T162437 | Bullish | Relevance: 100%
- Jim Cramer expressed bullish sentiment towards FedEx, predicting a "breakout quarter" for the company. Ariel Investments also highlighted FedEx's potential due to cost efficiencies, the planned spin-off of FedEx Freight, and operational improvements despite economic uncertainties. The company provides transportation, shipping, and logistics services globally.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Jefferies | $315 | $280 | +12% |
| 2025-12-09 | Evercore ISI Gr | $275 | $239 | +15% |
| 2025-12-08 | Wells Fargo | $290 | $280 | +4% |
| 2025-12-04 | Susquehanna | $345 | $300 | +15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Jefferies | main | Buy |
| 2025-12-09 | Evercore ISI Gr | main | In-Line |
| 2025-12-08 | Wells Fargo | main | Equal-Weight |
| 2025-12-04 | Susquehanna | main | Positive |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 12 ($0.49M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.9% (+13.2%)
- Blackrock Inc.: 7.2% (-2.5%)
- Dodge & Cox Inc.: 6.9% (+12.0%)
- Primecap Management : 4.0% (-6.4%)
- State Street Corpora: 3.9% (-2.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 5 raises (avg +9%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +4.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.27 suggests fair value with growth premium. Forward P/E 13.4x attractive for 15% earnings growth. Balance sheet: $1.1B free cash flow. Analyst sentiment positive (5 raises, avg +9%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $66.4B |
| Beta | 1.33 |
| 52W Range | $194.30 - $295.24 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.27 |
| Forward P/E | 13.4 |
| Current P/E | 15.4 |
| YoY Growth | 14.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.3% to 3.7% (+4.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.3pp (needs >4.0% for momentum thesis). MRS_5 at 1.7% confirms short-term momentum alignment. AM_20 at 3.4% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.71% (CS: 66) | Neutral |
| RSI_14 | 65.8 | Neutral |
| MACD Histogram | 0.21 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.091x | Above |
| vs SMA200 | 1.194x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $281.23
- **Stop Loss:** $269.67 (4.1% risk)
- **Target:** $304.35 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 103
- **Position Value:** $28,966.69
- **Portfolio %:** 28.97%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2025-12-18 (Est: $4.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.61 | $3.83 | +6.0% |
| 2025Q2 | $5.80 | $6.07 | +4.6% |
| 2025Q1 | $4.62 | $4.51 | -2.4% |
| 2024Q4 | $3.97 | $4.05 | +2.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*